Did we get there in time?

The World Health Organization’s Global Cancer Report has issued a stark warning: by 2050, nearly 35 million new cancer cases are projected annually, driven by population aging, demographic growth, and rising risk factors. If family members and caregivers are included, almost 92 percent of the global population will be directly or indirectly affected by this disease. These figures underscore a growing crisis that demands urgent action. Yet the report highlights a more troubling reality than mere statistics. The primary challenge in combating cancer today lies not in ignorance, but in implementation. For decades, we have questioned how to defeat cancer. Now, the report urges a shift in focus: why, with so much knowledge, do we continue arriving too late? The evidence is overwhelming, preventive measures, vaccination, early diagnosis, and timely treatment are all well understood. A few weeks can change the prognosis of a person. Knowledge exists, but the gap lies in translating it into effective care. Chile holds particular significance in this context. In recent years, the country has developed a robust institutional framework, including the National Cancer Law, the National Cancer Plan, and explicit guarantees for various diseases. The recent Oncological Health Alert represents a critical step forward, acknowledging the urgency of the issue and mobilizing extraordinary resources to address it. However, its greatest contribution may lie in reminding us that opportunity should not depend on exceptional alerts alone. It must become a permanent feature of the healthcare system. Cancer does not advance at the pace of budgets or administrative procedures, it advances according to biological rhythms. There is a persistent temptation in public policy to believe that innovation means simply incorporating more technology. But the WHO report suggests otherwise. The kind of innovation that can save the most lives is ensuring that individuals receive essential services such as biopsies, mammograms, colonoscopies, or radiation therapy before the disease progresses beyond reversal. Arriving earlier remains far more transformative than arriving later, even with better tools. This requires a different kind of conversation, one that goes beyond investment amounts and focuses instead on how care networks are organized, how data is used to anticipate needs, how territorial disparities are reduced, and how all available capacities are coordinated under clear rules to ensure no one loses opportunities due to their location or delays in bureaucratic processes. Cancer has become a test for health systems worldwide. Success is not measured by announcing more programs or adopting the most sophisticated technologies. It is determined by whether knowledge, resources, and opportunities reach people in time. This is the true measure of progress.